151 related articles for article (PubMed ID: 34433051)
21. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
Chetyrkin SV; Kim D; Belmont JM; Scheinman JI; Hudson BG; Voziyan PA
Kidney Int; 2005 Jan; 67(1):53-60. PubMed ID: 15610227
[TBL] [Abstract][Full Text] [Related]
22. Primary hyperoxaluria type 1: pathophysiology and genetics.
Fargue S; Acquaviva Bourdain C
Clin Kidney J; 2022 May; 15(Suppl 1):i4-i8. PubMed ID: 35592619
[TBL] [Abstract][Full Text] [Related]
23. Oxalate synthesis in mammals: properties and subcellular distribution of serine:pyruvate/alanine:glyoxylate aminotransferase in the liver.
Ichiyama A; Xue HH; Oda T; Uchida C; Sugiyama T; Maeda-Nakai E; Sato K; Nagai E; Watanabe S; Takayama T
Mol Urol; 2000; 4(4):333-40. PubMed ID: 11156700
[TBL] [Abstract][Full Text] [Related]
24. Hydroxyproline ingestion and urinary oxalate and glycolate excretion.
Knight J; Jiang J; Assimos DG; Holmes RP
Kidney Int; 2006 Dec; 70(11):1929-34. PubMed ID: 17021603
[TBL] [Abstract][Full Text] [Related]
25. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
van Woerden CS; Groothof JW; Wanders RJ; Waterham HR; Wijburg FR
Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1669-72. PubMed ID: 16922352
[TBL] [Abstract][Full Text] [Related]
26. Effect of alanine supplementation on oxalate synthesis.
Wood KD; Freeman BL; Killian ME; Lai WS; Assimos D; Knight J; Fargue S
Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165981. PubMed ID: 33002578
[TBL] [Abstract][Full Text] [Related]
27. Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I.
Martin-Higueras C; Luis-Lima S; Salido E
Mol Ther; 2016 Apr; 24(4):719-25. PubMed ID: 26689264
[TBL] [Abstract][Full Text] [Related]
28. Biogenesis of L-glyceric aciduria, oxalosis and renal injury in rats simulating type II primary hyperoxaluria.
Raghavan KG; Lathika KM; Gandhi NM; D'Souza SJ; Tarachand U; Ramakrishnan V; Singh BB
Biochim Biophys Acta; 1997 Dec; 1362(2-3):97-102. PubMed ID: 9540839
[TBL] [Abstract][Full Text] [Related]
29. Identification of a novel AGXT gene mutation in primary hyperoxaluria after kidney transplantation failure.
M'dimegh S; Omezzine A; Hamida-Rebai MB; Aquaviva-Bourdain C; M'barek I; Sahtout W; Zellama D; Souche G; Achour A; Abroug S; Bouslama A
Transpl Immunol; 2016 Nov; 39():60-65. PubMed ID: 27568336
[TBL] [Abstract][Full Text] [Related]
30. Effect of Vitamin B2-Deficient Diet on Hydroxyproline- or Obesity-Induced Hyperoxaluria in Mice.
Uebanso T; Suyama M; Shimohata T; Mawatari K; Takahashi A
Mol Nutr Food Res; 2021 Aug; 65(15):e2100226. PubMed ID: 34110671
[TBL] [Abstract][Full Text] [Related]
31. Metabolism of [13C5]hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria.
Jiang J; Johnson LC; Knight J; Callahan MF; Riedel TJ; Holmes RP; Lowther WT
Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(6):G637-43. PubMed ID: 22207577
[TBL] [Abstract][Full Text] [Related]
32. Generation of a Primary Hyperoxaluria Type 1 Disease Model Via CRISPR/Cas9 System in Rats.
Zheng R; Fang X; He L; Shao Y; Guo N; Wang L; Liu M; Li D; Geng H
Curr Mol Med; 2018; 18(7):436-447. PubMed ID: 30539697
[TBL] [Abstract][Full Text] [Related]
33. 4-Hydroxyproline metabolism and glyoxylate production: A target for substrate depletion in primary hyperoxaluria?
Coulter-Mackie MB
Kidney Int; 2006 Dec; 70(11):1891-3. PubMed ID: 17130820
[TBL] [Abstract][Full Text] [Related]
34. Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer.
Salido EC; Li XM; Lu Y; Wang X; Santana A; Roy-Chowdhury N; Torres A; Shapiro LJ; Roy-Chowdhury J
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18249-54. PubMed ID: 17110443
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of a New Gas Chromatography-Tandem Mass Spectrometry Method for the Measurement of Enrichment of Glyoxylate Metabolism Analytes in Hyperoxaluria Patients Using a Stable Isotope Procedure.
van Harskamp D; Garrelfs SF; Oosterveld MJS; Groothoff JW; van Goudoever JB; Schierbeek H
Anal Chem; 2020 Jan; 92(2):1826-1832. PubMed ID: 31867958
[TBL] [Abstract][Full Text] [Related]
36. CRISPR/Cas9-mediated metabolic pathway reprogramming in a novel humanized rat model ameliorates primary hyperoxaluria type 1.
Zheng R; Li Y; Wang L; Fang X; Zhang J; He L; Yang L; Li D; Geng H
Kidney Int; 2020 Oct; 98(4):947-957. PubMed ID: 32464217
[TBL] [Abstract][Full Text] [Related]
37. Glyoxylate reductase: Definitive identification in human liver mitochondria, its importance for the compartment-specific detoxification of glyoxylate.
Garrelfs SF; Chornyi S; Te Brinke H; Ruiter J; Groothoff J; Wanders RJA
J Inherit Metab Dis; 2024 Mar; 47(2):280-288. PubMed ID: 38200664
[TBL] [Abstract][Full Text] [Related]
38. Effect of vitamin B6 deficiency on glyoxylate metabolism in rats with or without glyoxylate overload.
Nishijima S; Sugaya K; Hokama S; Oshiro Y; Uchida A; Morozumi M; Ogawa Y
Biomed Res; 2006 Jun; 27(3):93-8. PubMed ID: 16847354
[TBL] [Abstract][Full Text] [Related]
39. The subcellular metabolism of glyoxylate in primary hyperoxaluria type 1: the relationship between glycine production and oxalate overproduction.
Thompson GN; Purkiss P; Danpure CJ
J Inherit Metab Dis; 1988; 11 Suppl 2():212-4. PubMed ID: 2903269
[No Abstract] [Full Text] [Related]
40. Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria.
Klimesova K; Whittamore JM; Hatch M
Urolithiasis; 2015 Apr; 43(2):107-17. PubMed ID: 25269440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
